Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LISI S.A. Earnings Release 2019

Feb 19, 2020

1484_iss_2020-02-19_ff959371-6d88-433d-829b-894396dd0637.pdf

Earnings Release

Open in viewer

Opens in your device viewer

News Release Paris, February 19, 2020

The LISI Group achieved its target of improving its financial performance in 2019

  • Reported sales up: +5.1% at €1,729.5M, return to positive organic growth1 (+3.3%);
  • +14.4% increase in EBIT with an acceleration in the second half of the year;
  • Net income of €69.8M, including non-recurring charges related to the disposals of businesses in the LISI AEROSPACE and LISI AUTOMOTIVE divisions. +6.3% increase compared to 2018, excluding this scope effect;
  • Record Free Cash Flow2 Level at €101.5M;
  • Outlook:
    • o The LISI Group remains alert to the timeline for the return to service of the B737 MAX to refine its objective of positive organic growth and EBIT increase in 2020.
    • o The Free Cash Flow will remain largely positive in 2020 given the Group's track record of adapting to changing conditions.

The LISI Board of Directors met under the chairmanship of Mr. Gilles Kohler and reviewed the final audited financial statements for the period ended December 31, 2019. They will be submitted for approval to the Ordinary General Meeting on April 24, 2020.

This English version is a translation of the original in French for information purposes only. In case of a discrepancy, the French original will prevail.

Summarized activity as at December 31st (after taking IFRS 16 into account since January 1, 2019)

12 months ending December 31, 2019 2018 Changes
Key elements of the income statement
Sales €M 1,729.5 1,645.1 +5.1%
EBITDA €M 273.2 225.4 +21.2%
EBITDA margin % 15.8 13.7 +2.1 pts
EBIT €M 155.1 135.6 +14.4%
Operating margin % 9.0 8.2 +0.8pt
Earnings attributable to holders of company equity €M 69.8 92.1 -24.2%
Net earnings per share 1.31 1.73 -24.3%
Key components of the cash flow statement
Operating cash flow €M 221.3 194.9 +€26.4M
Net industrial CAPEX €M -116.8 -131.3 -€14.5M
Free operating cash €M 101.5 57.3 +€44.2M
Key elements of the financial structure
Net debt €M 331.9 339.3 -€7.4M
Ratio of net debt to equity % 32.5 36.0 -3.5 pts

1 "Organic" means at constant exchange rates and perimeter.

2 "Free Cash Flow": net operating cash flow minus net capital expenditure and changes in working capital requirements

Sales reached €1,729.5M, up +€84.4M (+5.1%)

The analysis of sales takes into account the following elements:

  • a favorable currency effect of €38.2M or +2.2%;
  • a scope effect of +€3.6 M resulting from:
    • o +€28.9M from the integration into LISI AUTOMOTIVE of the US company Hi-Vol as of October 1, 2018;
    • o -€4.3M reflecting the sale of the German company Beteo (LISI AUTOMOTIVE) on December 31, 2018;
    • o -€28.2M from the deconsolidation of Indraero Siren and LISI AEROSPACE Creuzet Maroc carried out on June 30, 2019.

Consequently, at constant exchange rates and perimeter, sales increased by +€52.6M or +3.3% compared to 2018.

Q1 Q2 Q3 Q4 Total
2018 2019 2018 2019 2018 2019 2018 2019 2018 2019
LISI AEROSPACE 235.6 252.6 230.1 254.4 221.4 234.8 246.9 254.8 934,0 996.6
LISI AUTOMOTIVE 153.9 156,0 152.1 151.2 131.1 141.1 144,0 139.6 581.1 587.9
LISI MEDICAL 30.2 36.6 33.6 36,0 34,0 36.2 32.9 37.4 130.7 146.2
LISI Consolidated 419.5 445,0 415.6 441.3 386.3 411.9 423.7 431.4 1,645.1 1,729.5

Quarterly evolution of reported sales

Q4 analysis

At constant exchange rates and perimeter, Q4 sales increased by +5.0% compared to the same period of the previous year. The Group confirms the return to positive organic growth effective since the beginning of the year (Q1 2019: +1.0%; Q2: +1.6%; Q3: +5.7%; Q4: +5.0%).

Divisional analysis

The LISI AEROSPACE division's sales reached €996.6 million in 2019 (+6.7% compared to 2018). The impact of stronger currencies (mainly the US dollar against the euro) amounted to €30.0M and amplified growth. This positive momentum was driven by the "Fasteners" segment in Europe, which benefited fully from the accelerated production of single-aisle aircraft (Q4: +22.4%). In North America (Q4: +18.4%), maintaining a sustained level of activity in the markets other than commercial aviation (business, military, helicopters) helped to offset the effects linked to the lower production rates of the Boeing B737 MAX program. Conversely, the "Structural Components" segment (Q4: -17.6%) suffered on the one hand from the deconsolidation of Indraero Siren and LISI AEROSPACE Creuzet Maroc since July 1, 2019 and on the other hand from the effects of the slower production of the LEAP-1B engine for the Boeing B737 MAX. This deceleration was only partially offset by increases in the production rate of the LEAP-1A engine.

At constant exchange rates and perimeter, the LISI AEROSPACE division' sales increased by +8.3% in Q4 compared to 2018 and by +6.7% on a full-year basis.

The LISI AUTOMOTIVE division saw sales increase by +1.2% to €587.9M. This growth is linked to its international development (Hi-Vol consolidated since November 1, 2018). At constant exchange rates and perimeter, sales fell by -3.3% (Q4: -1.2%). The division is therefore outperforming its main customers, whose estimated production is down by -7.4% in 2019 compared to the previous year. The high valueadded activities of "Clipped Solutions" and "Safety Mechanical Components" segments are the most resilient, enjoying the positive momentum of the ramp-up of new products and market share gains achieved in recent years.

The synergies between the American company Termax and the historical sites of the division's "Clipped Solutions" segment also help to drive sales. It is the "Threaded Fasteners" segment, both in France and in Germany, that is most affected by the lack of volume.

As expected, the LISI MEDICAL division benefited from the ramp-up of new product contract wins in the minimally invasive surgery sector and from a favorable currency effect which compensated for the slowdown in activity in the two small sites of the division, LISI MEDICAL Fasteners (Neyron, France) and LISI MEDICAL Jeropa (United States), and the sharp drop in the dental sector. Sales for the year thus increased by +11.9% to €146.2M, an organic growth of +8.8%.

EBIT increased by 14.4%. Operating margin gained 0.8 point to 9.0%

Earnings Before Interest, Depreciation and Amortization (EBITDA) increased by +21.2% to €273.2M (or 15.8% of sales). Every divisions shows a sequential improvement between the first and second half, which is explained by the following factors:

  • the LISI AEROSPACE division was supported by volume increases in Europe in its "Fasteners" segment and the full effect of the productivity actions deployed in 2018. The "Structural Components" segment benefited from the continued ramp-up of the LEAP-1A engine programs over the entire financial year. The effects of lower LEAP-1B engine production rates were thus fully offset,
  • the performance of the LISI AUTOMOTIVE division reflect the first effects of the cost adjustment measures launched during Q4 2018,
  • the LISI MEDICAL division shows its ability to better control industrialization costs in the ramp-up phase of new products within its minimally invasive surgery activity.

Depreciation increased by +€20.2M because of the impact of major investment plans carried out in recent years and the IFRS 16 impact of +€12.3M. The provision reversals recorded against operating expenses of the same kind were down -€8.1M.

Earnings Before Interest and Taxes (EBIT-Current operating income) rose by €+19.5M (+14.4%) to €155.1M. At 9.0%, the operating margin increased by 0.8 point compared to 2018.

The strongly negative impact of financial losses (-€8.5M), compared to 2018 (+€5.3M), is explained by the following main factors:

  • revaluation of debts and receivables mainly denominated in US dollars (-€0.5M vs. +€12.7M in 2018),
  • negative impact of the fair value of currency hedging instruments (-€3.3M vs. -€4.1M in 2018),
  • higher financial costs corresponding to the cost of net debt. They amounted to -€7.6M (-€5.9M in 2018). They are lower than in 2018 after restatement of the IFRS 16 impact of -€2.1M. The average interest rate is 2.2% (2.1% excluding IFRS16). Gains on current cash investments amounted to +€3.2M (versus +€3.3M in 2018). Net financial expenses therefore amount to less than 1% of net financial debt.

Non-current expenses weighed on net profit for -€44.8M (-€10.3M in 2018). For the most part (-€40.5M, before taxes), they are attributable to the deconsolidation of Indraero Siren (Argenton-sur-Creuse), LISI AEROSPACE Creuzet Maroc and Saint-Florent-sur-Cher in the LISI AUTOMOTIVE division.

The tax expense, calculated on the basis of the corporation tax as a percentage of net income before taxes, reflects an effective average taxation rate of 27.4%, up from 2018 (25.9%).

Net income amounted to €69.8M, compared to €92.1M in 2018 (24.2%). Restated for the deconsolidation of Indraero Siren (Argenton-sur-Creuse), LISI AEROSPACE Creuzet Maroc and Saint-Florent-sur-Cher in the LISI AUTOMOTIVE division, it amounted to €97.9M, i.e. a net margin of 5.7% of sales (5.6% in 2018).

Per share, it amounts to €1.31 (€1.73 in 2018).

Based upon these results, the Group will submit to the Shareholders' Ordinary General Meeting a proposal to approve a dividend of €0.46 per share for the 2019 financial year.

Free Cash Flow reached the record level of €101.5M, significantly higher than in 2018 (€57.3M)

Cash flow reached €221.3M (+€12.8% of consolidated sales), compared to €194.9M in 2018. It includes an IFRS 16 impact of +€11.6M. It allowed for the financing of capital expenditure for €116.8M (6.8% of sales). Following on the previous phase of large infrastructure projects, capital expenditure focused on the development of new products, industrial productivity and better working conditions. Automation and robotization plans for manufacturing processes are continuing in line with the objectives set.

Thanks to a long-term action plan, the Group also continued to reduce its inventories to 76 days of sales, down by 7 days compared to 2018. Working capital requirement stood at 74 days, down 3 days from 2018.

Free Cash Flow increased by €44.2M and reached the record level of €101.5M.

The financial structure is strengthening

Net debt amounted to €331.9M, or 32.5% of shareholders' equity. Restated for the impact related to IFRS 16 (€76.8M), it decreased to €255M which represent 25.0% of equity (36.0% as of December 31, 2018). Net debt has improved from 1.2x EBITDA vs. 1.5x EBITDA as at December 31, 2018. The share of net financial debt, net from investments returns to a historically low level of €98.1M.

The return on capital employed (ROCE before tax) was up 0.6 point to 11.5%.

LISI AEROSPACE

  • Sales: €996.6M, up +6.7% (as reported and at constant exchange rates and perimeter) compared to 2018;
  • Initial effects of the lower production rates of the Boeing B737 MAX offset by the positive momentum on the other programs;
  • EBIT up +27.7%;
  • Free Cash Flow: record level of €85.7M;
  • Disposals of the companies Indraero Siren and LISI AEROSPACE Creuzet Maroc (Business Group "Structural Components") completed on June 30, 2019.
2019 2018 Change
Sales (€M) 996.6 934.0 +6.7%
At constant exchange rates and
perimeter
EBIT (€M) 123.6 96.8 +27.7%
As a % of sales 12.4% 10.4% +2.0 pts
Free Cash Flow (€M) 85.7 29.6 +€56.1M
As a % of sales 8.6% 3.2% +5.4 pts

LISI AUTOMOTIVE

  • +1.2% increase in published sales to €587.9M, supported by a full-year perimeter effect of the integration of Hi-Vol acquired in 2018 in the United States;
  • New market share gains in "Clipped Solutions" and "Safety Mechanical Components";
  • Sequential improvement in the operating margin between H1 and H2, reflecting the gradual effects of the cost-cutting actions launched in Q4 2018;
  • Record annual Free Cash Flow at €19.5M;
  • Disposal of the screw, chassis stud and ball joint segment by LISI AUTOMOTIVE Former completed on November 29, 2019 (amount of divested 2019 sales: €31.8M).
2019 2018 Change
Sales (€M) 587.9 581.1 -3.3%
At constant exchange rates and
perimeter
EBIT (€M) 21.9 34.0 -35.6%
As a % of sales 3.7% 5.9% -2.2 pts
Free Cash Flow (€M) 19.5 4.1 +€15.4M
As a % of sales 3.3% 0.7% +2.6 pts

LISI MEDICAL

  • Sales up +11.9% from 2018;
  • EBIT up +28.5% compared to 2018, driven by the recovery of LISI MEDICAL Remmele and the good performance of LISI MEDICAL Orthopedics;
  • Free Cash Flow increased by €3.7M compared to 2018.
2019 2018 Change
Sales (€M) 146.2 130.7 +8.8%
At constant
exchange rates and
perimeter
EBIT (€M) 7.2 5.6 +28.5%
As a % of sales 4.9% 4.3% +0.6 pt
Free Cash-Flow (€M) 3.0 -0.7 +€3.7M
As a % of sales 2.1% -0.5% +2.6 pts

OUTLOOK

The LISI AEROSPACE division has already taken measures to adapt its production capacities dedicated to the B737 MAX, to improve its efforts to develop new products and to gain market share, especially in the United States. This is demonstrated by the confirmation of LISI AEROSPACE as the first supplier of AIRBUS fasteners with the renewal of the current contract until 2026, on the one hand, and the major new contract won in December 2019 with MTU Aero Engines for the supply of compressor blades for the GTF engine for a period of 10 years, on the other hand. Benefiting from the positive momentum of the various activities, LISI AEROSPACE enters 2020 with renewed confidence in the robustness of its long-term development model which the current uncertainties around the requirements and timeline for the return to service of the B737 MAX does not affect.

LISI AUTOMOTIVE, which is looking at a global market decline (-2.0%) in 2020, will continue to develop high value-added parts and to intensify commercial and technical synergies with its American subsidiaries Termax and Hi-Vol. The cost reduction action plans underway, as well as the disposal of the chassis screws and steering pivots business, should help improve the division's profitability. The ramp-up of new products, the improvement of deliveries in certain areas (NAFTA in particular), the innovation policy, in particular towards multi-material assemblies, should help to consolidate business and adjust to a market that remains complex.

While LISI MEDICAL recorded signs of improvement in its minimally invasive surgery activity in 2019, the division should nonetheless continue to adapt the cost structures of the two small production sites. Positive relations with major customers reinforce the current strategic choices.

The LISI Group remains alert to the timeline for the return to service of the B737 MAX to refine its objective of positive organic growth and EBIT increase in 2020. This objective will be periodically reviewed based on market information that may be published during financial year 2020.

In this context, the LISI Group is prioritizing cash generation in the coming months. In this regard, the Free Cash Flow will remain largely positive in 2020 given the Group's track record of adapting to changing conditions.

Contact

Emmanuel Viellard Tel: +33 (0)3 84 57 00 77 Email: [email protected] Website: www.lisi-group.com

Financial calendar (releases scheduled after close of trading on Paris Euronext)

Q1 2020 financial information: April 23, 2020 Shareholders' Ordinary General Meeting: April 24, 2020 H1 2020 results July 24, 2020 Q3 2020 financial information: October 21, 2020

The LISI share is listed on Euronext Paris, compartment A and belongs to the CAC® AERO & DEF., CAC® All Shares, CAC® Industrials indices, under ISIN code: FR 0000050353. LISI is a worldwide leading manufacturer of fasteners and assembly components for the Aerospace, Automotive, and medical implants industries.

Reuters:GFII.PA Bloomberg:FII FP

Appendix

First application of IFRS 16, which increases debt by €76.8M

The Group has chosen to apply IFRS 16 according to the simplified retrospective approach that came into effect on January 1, 2019. This standard aligns the accounting for operating leases with finance lease contracts (except for exemptions provided for by the standard). The impact of IFRS 16 on the Group's consolidated financial statements mainly relates to real estate leases.

The implementation of this accounting standard has the following impacts on Financial Statements published as at December 31, 2019:

  • ⋅ On the balance sheet: recognition of a €76.8M debt in respect of future lease payments and an asset for the right of use,
  • ⋅ On the profit and loss account: the rental expense previously recognized in operating income for an amount of €13.7M has been reclassified, partly as a reduction of other external expenses for +€13.7M and as an increase in depreciation provisions for an amount of -€12.3M. The net impact on EBIT is +€1.4M.
  • ⋅ The financial result is reduced by -€2.1M.

⋅ The impact on net income was thus -€0.7M.

LISI Group consolidated balance sheet

ASSETS

(in €'000) 31/12/2019 31/12/2018
LONG-TERM ASSETS
Goodwill 354 552 347 787
Other intangible assets 29 393 26 975
Tangible assets 732 776 676 657
Long-term financial assets 16 977 8 923
Deferred tax assets 17 312 11 894
Other long-term assets 9 480
Total long-term assets 1 151 022 1 072 716
SHORT-TERM ASSETS
Inventories 321 639 351 009
Taxes – Claim on the state 16 206 22 032
Trade and other receivables 275 072 263 141
Cash and cash equivalents 236 809 156 879
Total short-term assets 849 727 793 061
TOTAL ASSETS 2 000 748 1 865 775

TOTAL EQUITY AND LIABILITIES

(in €'000) 31/12/2019 31/12/2018
SHAREHOLDERS' EQUITY
Share capital
Additional paid-in capital
Treasury shares
Consolidated reserves
Conversion reserves
Other income and expenses recorded directly as shareholders' equity
Profit (loss) for the period
21 646
75 329
(14 435)
844 386
21 819
(6 877)
69 773
21 646
75 329
(15 175)
757 720
12 339
(6 918)
92 069
Total shareholders' equity - Group's share 1 011 642 937 010
Minority interests 9 740 6 625
Total shareholders' equity 1 021 382 943 634
LONG-TERM LIABILITIES
Long-term provisions
Non-current financial debts
Other long-term liabilities
Deferred tax liabilities
64 993
412 310
10 705
40 091
65 475
337 354
8 452
37 745
Total long-term liabilities 528 099 449 025
SHORT-TERM LIABILITIES
Short-term provisions
Short-term borrowings*
Trade and other accounts payable
Taxes due
23 069
156 423
270 447
1 328
13 404
158 831
298 469
2 411
Total short-term liabilities 451 267 473 116
TOTAL SHAREHOLDERS' EQUITY AND LIABILITIES 2 000 748 1 865 775
* Of which banking facilities 8 273 20 480

LISI Group consolidated income

(in €'000) 31/12/2019 31/12/2018
Pre-tax sales 1 729 527 1 645 095
Changes in stock, finished products and production in progress (3 513) 9 251
Total production
Other revenues *
1 726 014
28 508
1 654 346
39 641
Total operating revenues 1 754 522 1 693 987
Consumed goods
Other purchases and external expenses
Taxes and duties
Personnel expenses (including temporary employees)
*
(476 490)
(349 499)
(11 995)
(643 338)
(464 424)
(352 485)
(11 615)
(640 048)
EBITDA 273 200 225 416
Depreciaion
Net provisions
(119 181)
1 094
(99 025)
9 166
EBIT 155 113 135 558
Non-recurring operating expenses
Non-recurring operating revenues
(46 358)
1 523
(13 693)
3 427
Operating result 110 278 125 290
Financing expenses and revenue on cash (4 326) (2 503)
Revenue from cash
Financing expenses
Other interest revenue and expenses
Other financial items
Other interest expenses
3 544
(7 871)
(4 221)
26 688
(30 909)
3 462
(5 965)
7 847
42 635
(34 788)
Taxes (of which CVAE (Tax on Companies' Added Value)** (27 918) (33 839)
Share of net income of companies accounted for by the equity method 0 0
Profit (loss) for the period 73 812 96 794
Attributable to company shareholders' equity
Interest not granting control over the company
69 773
4 039
92 069
4 725
Earnings per share (in €): 1,31 1,73
Diluted earnings per share (in €): 1,30 1,72

LISI Group consolidated cash flow table

(in €'000) 31/12/2019 31/12/2018
Operating activities
Net Profit (Loss) 73 812 96 794
Elim. of the income of companies accounted for by the equity method
Elimination of net expenses not affecting cash flows:
- Depreciation and non-recurrent financial provisions 119 418 98 634
- Changes in deferred taxes (3 467) 2 333
- Income on disposals, provisions for liabilities and others 34 797 1 393
Gross cash flow margin 224 560 199 154
Net changes in provisions provided by or used for current operations
Operating cash flow
(3 299)
221 261
(4 303)
194 853
Income tax expense (revenue) 31 385 31 506
Elimination of net borrowing costs 5 526 5 767
Effect of changes in inventory on cash 10 498 (5 744)
Effect of changes in accounts receivable and accounts payable (18 740) (16 645)
Net cash provided by or used for operations before tax 249 929 209 735
Taxes paid (26 108) (15 434)
Cash provided by or used for operations (A) 223 824 194 302
Investment activities
Acquisition of consolidated companies (702)
Cash acquired (43 384)
Acquisition of tangible and intangible fixed assets (118 555) (134 103)
Acquisition of financial assets
Change in granted loans and advances (187) (267)
Investment subsidies received
Dividends received
Total cash used for investment activities (118 742) (178 455)
Divested cash (1 249) (267)
Disposal of consolidated companies 3 000 3 191
Disposal of tangible and intangible fixed assets 1 737 2 822
Disposal of financial assets (3)
Total cash from disposals 3 485 5 746
Cash provided by or used for investment activities (B) (115 257) (172 710)
Financing activities
Capital increase 3 167
Net disposal (acquisition) of treasury shares
Dividends paid to shareholders of the Group
(23 421) (25 499)
Dividends paid to minority interests of consolidated companies (1 769) (1 879)
Total cash from equity operations (25 190) (24 211)
Issue of long-term loans 60 520 30 653
Issue of short-term loans 103 674 102 739
Repayment of long-term loans (5 882) (6 783)
Repayment of short-term loans
Net interest expense paid
(147 088)
(5 534)
(161 420)
(5 766)
Total cash from operations on loans and other financial liabilities 5 690 (40 576)
Cash provided by or used for financing activities (C) (19 501) (64 789)
Effect of change in foreign exchange rates (D) 2 338 (1 149)
Effect of adjustments in treasury shares (D) * 727 (390)
Changes in net cash (A+B+C+D) 92 133 (44 736)
Cash at January 1st (E) 136 400 181 135
Cash at year end (A+B+C+D+E) 228 533 136 400
Cash and cash equivalents 236 809 156 879
Short-term banking facilities (8 273) (20 479)

Change in LISI Group consolidated shareholders' equity

(
in €
'000
)
Sh
ital
are
ca
p
Prim
liée
es
s a
u
(
ital
Not
cap
e
)
7.3
Tre
har
asu
ry s
es
Co
lida
ted
nso
res
erv
es
Co
rsio
nve
n
res
erv
es
Oth
er i
d
nco
me
an
exp
ens
es
ord
ed
dire
ctly
rec
sha
reh
old
'
as
ers
ity
equ
Pro
fit f
he
or t
iod
per
, gr
oup
sha
re
Gro
's s
har
f
up
e o
sha
reh
old
'
ers
ity
equ
Min
orit
y
inte
ts
res
Tot
al s
har
eho
lde
rs'
ity
equ
Sh
hol
der
s' e
ity
at J
1,
201
8
are
qu
as
anu
ary
21
610
72
584
(
14
720
)
688
88
2
8 4
19
5 2
61
107
96
5
890
00
1
7 6
64
897
66
5
fit (
)
for
(a
)
Pro
loss
the
riod
N
pe
Tra
nsla
tion
dif
fere
ntia
l (
b)
Pay
in
sha
(c
)
nts
me
res
Ca
ital
inc
p
rea
se
Res
of
har
(
d)
tate
nts
trea
me
sur
y s
es
Res
r IA
S19
(g
)
tate
nts
me
as
pe
Ap
iatio
f N
-1 e
ing
pro
pr
n o
arn
s
Ch
e in
ang
sc
ope
Div
ide
nds
dis
trib
d
ute
36 2 7
45
(
)
455
614
107
96
5
(
14
371
)
(
25
499
)
3 9
20
(
)
300
(
3 0
79)
92
069
(
107
96
5)
92
069
3 9
20
614
2 7
81
(
)
755
(
3 0
79)
0
(
14
371
)
(
25
)
499
4 7
25
(
126
)
470
(
2 5
27)
(
1 8
79)
96
794
3 7
94
614
3 2
51
(75
5)
(
3 0
79)
0
(
16
898
)
(
27
378
)
Rec
lass
ifica
tion
Res
of
fina
ncia
l ins
s (
f)
tate
nts
trum
ent
me
s (e
)
Va
riou
128 (
8 8
00)
0
(
8 8
00)
128
(5
)
(
98)
1 6
0
(
8 8
05)
(
70)
1 5
Sh
hol
der
s' e
ity
at D
mb
er 3
1, 2
018
are
qu
as
ece
21
646
75
329
(
15
175
)
757
72
0
12
339
(
6 9
18)
92
069
937
01
0
6 6
25
943
63
4
inc
lud
ing
to
tal
and
ste
d fo
rev
enu
es
ex
pen
ses
po
r
the
rio
d (a
) +
(
b)
+ (
c)
+ (
d) +
( e
) +
(
f)
pe
3 9
20
(
12
179
)
92
069
83
810
4 5
94
88
404
Sh
hol
der
s' e
ity
at J
1,
201
9
are
qu
as
anu
ary
21
646
75
329
(
15
175
)
757
72
0
12
339
(
6 9
18)
92
069
937
01
0
6 6
25
943
63
4
Pro
fit (
loss
)
for
the
riod
N
(a
)
pe
69
773
69
773
4 0
39
73
812
dif
fere
l (
b)
Tra
nsla
tion
ntia
Pay
in
sha
(c
)
nts
me
res
Ca
ital
inc
p
rea
se
Res
of
har
(
d)
tate
nts
trea
me
sur
y s
es
Res
r IA
S19
(g
)
tate
nts
me
as
pe
Ap
iatio
f N
-1 e
ing
pro
pr
n o
arn
s
Ch
e in
ang
sc
ope
Div
ide
nds
dis
trib
ute
d
Rec
lass
ifica
tion
s (
f)
Res
tate
nts
of
fina
ncia
l ins
trum
ent
me
0 740 104
92
069
14
352
(
23
420
)
9 4
80
183
(
07)
3 4
3 2
65
(
92
069
)
9 4
80
104
0
923
(
07)
3 4
0
14
352
(
23
420
)
0
3 2
65
(
67)
947
(
48)
(
1 7
69)
14
9 4
13
104
947
923
(
07)
3 4
0
14
304
(
25
189
)
0
3 2
79
Va
riou
s (e
)
3 5
62
3 5
62
3 5
62
Sh
hol
der
s' e
ity
at J
30
, 20
19
are
qu
as
une
21
646
75
329
(
14
435
)
844
38
6
21
819
(
6 8
77)
69
773
1 0
11
642
9 7
40
1 0
21
382
inc
ing
d fo
lud
to
tal
and
ste
rev
enu
es
ex
pen
ses
po
r
d (a
) +
(
b)
+ (
c)
+ (
d) +
( e
) +
(
f) +
(g
)
the
rio
pe
9 4
80
41 69
773
79
294
3 9
86
83
279